Li-Na Gao | Pharmacology | Best Researcher Award | 13230

Posted on by sciencefather

Assoc. Prof. Dr. Li-Na Gao | Pharmacology | Best Researcher AwardĀ 

Assoc. Prof. Dr. Li-Na Gao, Jining Medical University, China

Assoc. Prof. Dr. Li-Na Gao is a postdoctoral fellow at the University of British Columbia and an academic leader at Jining Medical University, China. Her research focuses on neuropsychopharmacology and anti-inflammatory immune pharmacology of traditional Chinese medicine (TCM). She has led multiple research projects, published over 40 academic papers (H-index: 21, citations: 1,900+), and collaborates on innovative TCM drug development. Dr. Gao holds key editorial and professional memberships, contributing significantly to TCM research, particularly in cardiovascular and cerebrovascular diseases, inflammation, and gut-brain interaction. She has secured Ā„1.04 million in research funding and actively promotes TCM modernization.

Profile

Scopus

Early Academic Pursuits šŸŽ“

Dr. Li-Na Gao embarked on her academic journey with a strong foundation in Traditional Chinese Medicine (TCM), leading her to become an esteemed researcher and educator in the field. Her passion for TCM and its applications in modern pharmacology inspired her to pursue advanced studies. After earning her Ph.D., she further honed her expertise as a postdoctoral fellow at the University of British Columbia. Her early academic years were marked by rigorous research into the pharmacological mechanisms of TCM, setting the stage for her later contributions to neuropsychopharmacology and inflammatory immune pharmacology.

Professional Endeavors šŸ’¼

Currently serving as an Associate Professor at Jining Medical University, Dr. Gao plays a crucial role in advancing the field of TCM. She has established herself as an academic leader in key TCM disciplines in Shandong Province. With her extensive background, she has been instrumental in mentoring students, conducting cutting-edge research, and collaborating with renowned institutions. Her work extends beyond academia, encompassing consultancy projects and significant contributions to the development of TCM-based treatments.

Contributions and Research Focus šŸ“

Dr. Gaoā€™s research is primarily centered on the neuropsychopharmacology and inflammatory immune pharmacology of TCM. She has made significant contributions in the following areas:

  • Heart, Brain, and Intestine Disease Correlation:Ā She has explored the scientific underpinnings of TCM theories, such as “the heart dominates the mind, and the small intestine is exterior to interior.”
  • Inflammatory Metabolic Damage and Depression:Ā She has pioneered the understanding that inflammatory metabolic damage is a key pathological mechanism of depression and its co-occurrence with somatic diseases.
  • Intestinal-Brain Communication:Ā Her work has identified TLR4 as the critical “bridge molecule” in mediating inflammatory metabolic disorders, enhancing our understanding of gut-brain interactions.
  • Secondary Development of TCM:Ā She has provided significant insights into the mechanisms of Gegen Qinlian decoction, Scrophularia ningpoensis Hemsl., puerarin, and glycyrrhizic acid, thereby enhancing their applications in modern medicine.

Accolades and Recognition šŸ†

Dr. Gao has been recognized for her outstanding contributions to research and academia. She has published over 40 academic papers, boasting an H-index of 21 and more than 1,900 citations. Her editorial appointments include:

  • Visiting Deputy Editor-in-Chief ofĀ Frontiers in PharmacologyĀ (2021ā€“Present)
  • Youth Editorial Board Member ofĀ Acupuncture and Herb MedicineĀ (2022ā€“2024)
  • Youth Editorial Board Member ofĀ Advanced Gut & Microbiome ResearchĀ (2022ā€“2023)
  • Youth Editorial Board Member ofĀ Tianjin Traditional Chinese MedicineĀ (2023ā€“Present)

She has also been an integral part of major collaborative research projects, including a 1.04 million RMB-funded project on acute and chronic inflammatory diseases in cooperation with Rizhao Hospital of Traditional Chinese Medicine.

Impact and Influence šŸŒ

Dr. Gaoā€™s research has had a profound impact on the global TCM community. Her contributions extend beyond research papers and patents to shaping policies and educational curriculums. As a standing committee member of multiple prestigious organizations, she has influenced the standardization and modernization of TCM research. Her work in bridging the gap between traditional medicine and modern pharmacology has helped in integrating TCM into contemporary medical practices.

Publication Top Notes

Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy

Author: Xu, D., Gao, L.-N., Song, X.-J., … Cui, Y.-L., Wang, Q.

Journal: Nanobiotechnology

Year: 2023

Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats

Author: Huang, M., He, Y., Tian, L., … Gao, S., Yu, C.

Journal: Affective Disorders

Year: 2023

Polysaccharides fromĀ Scrophularia ningpoensisĀ Hemsl. improve reserpine-induced depression-like behavior by inhibiting HTR2A/HTR2C mediated AKT/GSK3Ī²/Ī²-catenin/CBP/BDNF signalling

Author: Ruhui Shen, Jian’an Wang, Yijin Zhao, Zhaojin Dang , Ke Zhang, Ming Li , Qian Yang , Li-Na Gao

Journal: Biological Molecules

Year: 2025

Avat Arman Taherpour | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Prof Dr. Avat Arman Taherpour | Medicinal Chemistry | Best Researcher Award

Professor at Al-Balqa Applied University, Jordan

Avat Arman Taherpour is a distinguished Professor of Organic Chemistry at Razi University, Kermanshah, Iran, and a respected researcher at the Medical Biology Research Center, Kermanshah University of Medical Sciences. With a Ph.D. in Organic Chemistry from Islamic Azad University, Tehran, and post-doctoral experience at The University of Queensland, Australia, under Professor Curt Wentrup, he specializes in computational chemistry, organic synthesis, and nano-chemistry. Avat’s research focuses on applying quantum mechanical methods to study molecular structures and interactions, essential for advancing medicinal chemistry and nano-materials. He has authored numerous publications and holds international recognition, listed among the top 2% researchers worldwide. Beyond academia, Avat has held significant managerial roles, including President of the Elites Foundation in Kermanshah Province, Iran, emphasizing his leadership in fostering scientific excellence and industry collaboration. His contributions continue to shape the fields of theoretical chemistry and organic synthesis globally.

Professional Profiles:

šŸŽ“ Education

Avat Arman Taherpour pursued his academic journey with a strong foundation in chemistry, earning a B.Sc. in Applied Chemistry from Islamic Azad University, Tehran, Iran in 1990. He continued his studies with an M.Sc. in Organic Chemistry from the same institution in 1992, further deepening his expertise in chemical sciences. Avat Arman Taherpour completed his academic trajectory with a Ph.D. in Organic Chemistry from the Islamic Azad University Science and Research Branch, Tehran, Iran, in 1998. His educational background provided him with a robust theoretical framework and practical skills essential for his subsequent research and professional endeavors in the field of organic chemistry.

Ā Professional Experience

Avat Arman Taherpour is a distinguished Professor of Organic Chemistry at Razi University, Kermanshah, Iran, where he also serves as an invited researcher at the Medical Biology Research Center, Kermanshah University of Medical Sciences. With a robust academic background, including a Ph.D. in Organic Chemistry and post-doctoral research at The University of Queensland, Australia, he specializes in Organic and Medicinal Chemistry, Quantum Mechanical and Computational Chemistry, and Nano-Chemistry. Avat has held significant administrative roles, such as President of the Elites Foundation for Kermanshah Province and Head of the Nano-Chemistry Department at Razi University. His career highlights include fostering industry-academia partnerships and contributing extensively to the advancement of scientific research and education in Iran.

Research Interest

Avat Arman Taherpour’s research interests encompass a wide array of fields within chemistry, focusing primarily on Organic and Medicinal Chemistry. His expertise extends to Quantum Mechanical and Computational Chemistry, Molecular Modeling, Theoretical Chemistry, and Physical Organic Chemistry. He is deeply engaged in Spectroscopic Studies of Organic Compounds and Nano-Chemistry, exploring innovative applications and theoretical frameworks. Avat’s research aims to bridge theoretical insights with practical applications, emphasizing the role of computational tools in enhancing experimental outcomes and understanding molecular interactions. His work underscores the importance of advancing chemical sciences through interdisciplinary approaches, particularly in areas like biochemistry, nano-systems, and medicinal chemistry, thereby contributing to both theoretical advancements and practical innovations in the field.

Award and Honors

Avat Arman Taherpour has been recognized internationally for his contributions to the field of chemistry, notably being listed among the top 2% researchers worldwide in all fields in 2019, 2020, and 2021. This prestigious recognition underscores his significant impact and scholarly contributions to scientific research. His achievements reflect his dedication to advancing knowledge in Organic and Medicinal Chemistry, Quantum Mechanical and Computational Chemistry, and Nano-Chemistry. Avat’s commitment to excellence in research and his innovative approaches have earned him acclaim within the global scientific community, highlighting his influential role in pushing the boundaries of chemical sciences

Research Skills

Avat Arman Taherpour is a distinguished researcher with a profound expertise in various domains of chemistry. His research skills encompass computational chemistry, where he applies advanced quantum mechanical methods to explore molecular structures and interactions, particularly in organic and medicinal chemistry. He is adept at organic synthesis, having designed and synthesized intricate compounds pivotal for drug development. Utilizing spectroscopic techniques such as NMR, IR, and UV spectroscopy, Avat characterizes organic and medicinal compounds with precision, elucidating their structural properties. His proficiency extends to nano-chemistry, where he investigates nano-scale materials for diverse applications in chemical sciences. Additionally, Avat’s knowledge in physical organic chemistry enables him to delve into reaction mechanisms and the physical properties of organic compounds, essential for enhancing synthetic strategies and understanding chemical behaviors. His comprehensive skill set integrates theoretical insights with practical applications, positioning him as a leading figure in advancing innovative research at the intersection of chemistry disciplines.

Publications

  1. Molecular modelling of fullerene C60 functionalized by nitric oxide for use in biological environment
    • Authors: Moztarzadeh, O., Jamshidi, M., Taherpour, A.A., Babuska, V.
    • Year: 2024
    • Journal: Scientific Reports
    • Volume: 14(1)
    • Pages: 2565
  2. Nitrile Imine Cyclizations and Rearrangements: N-Phenyl-C-styrylnitrile Imine and N-Phenyl-C-phenylethynylnitrile Imine
    • Authors: Miri, M., Taherpour, A.A., Wentrup, C.
    • Year: 2024
    • Journal: Journal of Organic Chemistry
    • Volume: 89(13)
    • Pages: 9360ā€“9370
  3. Modeling of an efficient donor-Ļ€-acceptor-Ļ€ organic solar cell: a first principle study of a holeā€“electron process by DFT and TD-DFT study
    • Authors: Hassani Daramroudi, A., Taherpour, A.A., Jamshidi, M.
    • Year: 2024
    • Journal: Journal of the Iranian Chemical Society
    • Volume: 21(5)
    • Pages: 1353ā€“1368
  4. Ni0.5Co0.5WO4@f-MWCNTs/GO nanocomposite with improved supercapattery activity as the electrode for asymmetric supercapacitor device
    • Authors: Abdolahi, B., Gholivand, M.B., Shamsipur, M., Mirzaei, M., Daramroudi, A.H., Taherpour, A.A.
    • Year: 2023
    • Journal: Journal of Energy Storage
    • Volume: 73
    • Pages: 109181
    • Citations: 9
  5. Experimental and computational investigation of multi-walled carbon nanotubes decorated by Coā€“Niā€“Se@MoSe2 coreā€“shell as a sustainable counter electrode for dye-sensitized solar cells
    • Authors: Norouzibazaz, M., Gholivand, M.B., Taherpour, A.A., Mirzaei, M.
    • Year: 2023
    • Journal: Materials Today Energy
    • Volume: 38
    • Pages: 101447
    • Citations: 5
  6. Corrigendum to: Synthesis and Application of Nano Vanadium-Oxo Pyridiniumporphyrazinato Sulfonic Acid for Synthesizing Pyrazole and Dihydropyrano [2,3] pyrazole Derivatives
    • Authors: Moeinimehr, M., Safaiee, M., Zolfigol, M.A., Taherpour, A.A.
    • Year: 2023
    • Journal: ChemistrySelect
    • Volume: 8(16)
    • Pages: e202204422
  7. Zwitterionic hydrogen-bonded organic framework (ZHOF): a metal-free water oxidation proton relay in alkaline and neutral media
    • Authors: Azizi, R., Shamsipur, M., Taherpour, A., Pashabadi, A.
    • Year: 2023
    • Journal: Journal of Materials Chemistry A
    • Volume: 11(3)
    • Pages: 1491ā€“1502
    • Citations: 7
  8. Catalytic synergism in Mn-heterostructured molybdenum oxysulfide hybridized with transition metal phosphides: A robust amorphous water oxidation catalyst
    • Authors: Ahanjan, K., Shamsipur, M., Taherpour, A., Pashabadi, A.
    • Year: 2022
    • Journal: Electrochimica Acta
    • Volume: 433
    • Pages: 141249
    • Citations: 4
  9. An ideal ratiometric fluorescent probe provided by the surface modification of carbon dots for the determination of Pb2+
    • Authors: Paydar, S., Feizi, F., Shamsipur, M., Taherpour, A.A., Jamshidi, M.
    • Year: 2022
    • Journal: Sensors and Actuators B: Chemical
    • Volume: 369
    • Pages: 132243
    • Citations: 23
  10. Retraction: Experimental and theoretical studies of the nanostructured {Fe3O4@SiO2@(CH2)3Im}C(CN)3 catalyst for 2-amino-3-cyanopyridine preparation via an anomeric based oxidation
    • Authors: Zolfigol, M.A., Kiafar, M., Yarie, M., Taherpour, A., Saeidi-Rad, M.
    • Year: 2022
    • Journal: RSC Advances
    • Volume: 12(42)
    • Pages: 27114

 

 

EMAD MOLAEI | Pharmaceutical Science | Young Scientist Award

Posted on by sciencefather

Dr. EMAD MOLAEI | Pharmaceutical Science | Young Scientist Award

Clinical pharmacy resident at Tehran University of Medical Sciences, Iran.

Dr. Emad Molaei is a PGY3 Pharmacotherapy Resident at Tehran University of Medical Sciences/Imam Khomeini Hospital Complex. With a PharmD from Mashhad University of Medical Sciences and a current residency in Pharmacotherapy, he has a strong foundation in clinical pharmacy. His research focuses on nephroprotective activity, cardiovascular diseases, and COVID-19 treatments, with several first-author publications in renowned journals. Dr. Molaei’s professional experience includes roles as a community pharmacist, medication consultant, and pharmacotherapy interventionist in various hospitals. He is also the Founder and Director of the R&D Department at Daneshafza Razi Pharmaceutical Company. Recognized for his academic excellence, he has received multiple awards and honors, including being the top-ranked graduate and outstanding student at each academic level. Dr. Molaei is skilled in data analysis, scientific writing, and project management, contributing significantly to his field.

Professional Profiles:

Education šŸŽ“

šŸŽ“ Emad Molaei is currently pursuing his Pharmacotherapy (Clinical Pharmacy) residency at the School of Pharmacy, Tehran University of Medical Sciences (TUMS), since September 2021. He completed his Pharm-D at the School of Pharmacy, Mashhad University of Medical Sciences (MUMS) in September 2021, achieving a commendable total average of 18.00. Prior to that, he earned his Diploma of Science from the Gifted Program in the National Organization for Development, with an impressive total average of 19.46 in September 2015.

Professional Experience

šŸ‘Øā€āš•ļø Emad Molaei’s professional journey includes his current role as a PGY3 Pharmacotherapy Resident at Tehran University of Medical Sciences / Imam Khomeini Hospital Complex. He has extensive clinical experience as a Community Pharmacist at 13-Aban TUMS Community Chain Pharmacy in Tehran and Razavi Pharmaceutical Service Institute in Mashhad. Additionally, he has served as a Medication Consultant at the Drug and Poison Information Center (DPIC) in Tehran and has been involved in pharmacotherapy interventions at several hospitals, including Imam Khomeini, Shariati, Sina, and Roozbeh Hospitals in Tehran. Emad also has experience working in the satellite pharmacy of the critical care department at Sina Hospital and initiated activities in the clean room dedicated to cytotoxic drug production at the Cancer Institute, Imam Khomeini Hospital Complex. Beyond his clinical roles, he has contributed as a Research Assistant and Teacher Assistant in Pharmacotherapy, Pharmacology, and Toxicology.

Research Interest

šŸ”¬ Emad Molaei’s research interests span across various aspects of clinical pharmacy and pharmacotherapy. He is particularly focused on the nephroprotective activity of natural products against chemical toxicants and the role of the Nrf2/ARE signaling pathway. Emad also investigates the therapeutic potential of Resolvin D1 in Acute Respiratory Distress Syndrome and explores emerging therapeutic targets for cardiovascular diseases, including the LKB1 pathway and the Mas receptor. Additionally, he is involved in clinical studies evaluating the efficacy and safety of treatments for burn patients, such as silver sulfadiazine 1%-cerium nitrate 2.2% cream. Emad’s work also extends to the treatment of COVID-19 with Remdesivir in special populations, showcasing his commitment to addressing critical health issues through innovative research.

Award and Honors

šŸ† Emad Molaei has received numerous awards and honors throughout his academic and professional career. He was recognized as the most outstanding student at each academic level and graduated as the top-ranked student from the Mashhad Faculty of Pharmacy. Emad also achieved the highest rank in the pharmacy specialty examination and is a member of the Brilliant Academic Talent Program. His presentation skills have been acknowledged with the best poster award at the 12th subspecialty congress of Iranian burn physicians. Emad’s dedication to excellence is further demonstrated by his active membership in various professional organizations and his role as the Founder and Director of the R&D Department at Daneshafza Razi Pharmaceutical Company.

Research Skills

šŸ§Ŗ Emad Molaei possesses a robust set of research skills. He is proficient in data analysis using software such as SPSS, GraphPad Prism, and Sigma Plot. His scientific writing abilities are well-honed, and he is adept with EndNote and Microsoft Office tools. Emad’s project management skills are complemented by his experience as a Research Assistant and Teacher Assistant in Pharmacotherapy, Pharmacology, and Toxicology. His clinical research experience includes participation in multiple clinical trials and studies, showcasing his ability to handle complex research projects effectively.

Publications by Emad Molaei

  1. Remdesivir: Treatment of COVID-19 in Special Populations
    • Authors: Molaei, E., Molaei, A., Hayes, A.W., Karimi, G.
    • Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
    • Year: 2024
    • Citations: 1
  2. Mas Receptor: A Potential Strategy in the Management of Ischemic Cardiovascular Diseases
    • Authors: Molaei, A., Molaei, E., Hayes, A.W., Karimi, G.
    • Journal: Cell Cycle
    • Year: 2023
    • Citations: 5
  3. LKB1: An Emerging Therapeutic Target for Cardiovascular Diseases
    • Authors: Molaei, A., Molaei, E., Sadeghnia, H., Hayes, A.W., Karimi, G.
    • Journal: Life Sciences
    • Year: 2022
    • Citations: 13
  4. Resolvin D1: Therapeutic Target in Acute Respiratory Distress Syndrome
    • Authors: Molaei, E., Molaei, A., Hayes, A.W., Karimi, G.
    • Journal: European Journal of Pharmacology
    • Year: 2021
    • Citations: 18
  5. Nephroprotective Activity of Natural Products Against Chemical Toxicants: The Role of Nrf2/ARE Signaling Pathway
    • Authors: Molaei, E., Molaei, A., Abedi, F., Hayes, A.W., Karimi, G.
    • Journal: Food Science and Nutrition
    • Year: 2021
    • Citations: 23